InspireMD Stock Price, News & Analysis (NYSEAMERICAN:NSPR)

$0.18 -0.01 (-5.26 %)
(As of 01/18/2018 04:52 AM ET)
Previous Close$0.19
Today's Range$0.17 - $0.19
52-Week Range$0.02 - $2.88
Volume6.58 million shs
Average Volume23.38 million shs
Market Capitalization$1.13 million
P/E Ratio-0.10
Dividend YieldN/A
Beta1.24

About InspireMD (NYSEAMERICAN:NSPR)

InspireMD logoInspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Receive NSPR News and Ratings via Email

Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorHealthcare
SymbolNYSEAMERICAN:NSPR
CUSIPN/A
Phone+1-857-4536553

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-0.102272727272727
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($1.76)
Net IncomeN/A
Net Margins-290.53%
Return on Equity-175.74%
Return on Assets-104.46%

Miscellaneous

EmployeesN/A
Outstanding Shares7,470,000

InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions

What is InspireMD's stock symbol?

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

How were InspireMD's earnings last quarter?

InspireMD Inc (NYSEAMERICAN:NSPR) issued its quarterly earnings data on Tuesday, November, 7th. The medical equipment provider reported ($0.19) earnings per share for the quarter. InspireMD had a negative net margin of 290.53% and a negative return on equity of 175.74%. View InspireMD's Earnings History.

When will InspireMD make its next earnings announcement?

InspireMD is scheduled to release their next quarterly earnings announcement on Wednesday, March, 28th 2018. View Earnings Estimates for InspireMD.

Are investors shorting InspireMD?

InspireMD saw a increase in short interest in the month of December. As of December 29th, there was short interest totalling 1,460,082 shares, an increase of 1.7% from the December 15th total of 1,435,388 shares. Based on an average trading volume of 3,577,806 shares, the days-to-cover ratio is currently 0.4 days. Currently, 3.2% of the company's shares are sold short.

Who are some of InspireMD's key competitors?

Who are InspireMD's key executives?

InspireMD's management team includes the folowing people:

  • Paul S. Stuka, Chairman of the Board (Age 61)
  • James J. Barry Ph.D., President, Chief Executive Officer, Director (Age 57)
  • Isaac Blech, Independent Vice Chairman of the Board (Age 66)
  • Craig Shore, Chief Financial Officer, Chief Administrative Officer, Treasurer and Secretary (Age 55)
  • Agustin V. Gago, Executive Vice President, Chief Commercial Officer (Age 57)
  • Thomas J. Kester CPA, Director (Age 69)
  • Michael Berman, Independent Director (Age 58)
  • Campbell Rogers M.D., Independent Director (Age 54)

Who owns InspireMD stock?

InspireMD's stock is owned by a number of of institutional and retail investors. Top institutional investors include SABBY MANAGEMENT, LLC (9.99%) and SABBY MANAGEMENT, LLC (9.99%). View Institutional Ownership Trends for InspireMD.

How do I buy InspireMD stock?

Shares of InspireMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is InspireMD's stock price today?

One share of InspireMD stock can currently be purchased for approximately $0.18.

How big of a company is InspireMD?

InspireMD has a market capitalization of $1.13 million.

How can I contact InspireMD?

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.


MarketBeat Community Rating for InspireMD (NSPR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  64 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  121
MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

InspireMD (NYSEAMERICAN:NSPR) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

InspireMD (NYSEAMERICAN:NSPR) Consensus Price Target History

Price Target History for InspireMD (NYSEAMERICAN:NSPR)

InspireMD (NYSEAMERICAN:NSPR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
3/29/2016Rodman & RenshawLower Price TargetBuy$4.00 -> $3.00View Rating Details
(Data available from 1/18/2016 forward)

Earnings

InspireMD (NYSEAMERICAN:NSPR) Earnings History and Estimates Chart

Earnings by Quarter for InspireMD (NYSEAMERICAN:NSPR)

InspireMD (NYSEAMERICAN NSPR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/28/2018N/AView Earnings Details
11/7/2017Q3 2017($0.19)ViewN/AView Earnings Details
8/8/2017Q2 2017($0.21)$0.64 millionViewN/AView Earnings Details
5/9/2017Q1 2017($0.81)ViewN/AView Earnings Details
2/16/2017Q4 2016($0.88)ViewN/AView Earnings Details
11/14/2016Q3 2016($0.86)$0.47 millionViewN/AView Earnings Details
8/9/2016Q216($0.17)($0.19)$0.80 million$0.54 millionViewN/AView Earnings Details
5/10/2016Q1 2016($8.75)($8.00)ViewN/AView Earnings Details
3/28/2016Q415($0.46)($0.37)$0.80 million$0.52 millionViewN/AView Earnings Details
11/10/2015Q315($0.50)($0.45)$0.63 millionViewListenView Earnings Details
8/5/2015Q215($0.05)($0.05)$0.69 millionViewN/AView Earnings Details
5/11/2015Q214($0.05)($0.08)$0.90 million$0.48 millionViewListenView Earnings Details
3/12/2015Q4 2014($0.17)($0.12)$0.07 million$0.87 millionViewN/AView Earnings Details
11/12/2014Q3 2014($55.00)($50.00)ViewN/AView Earnings Details
7/23/2014Q2 2014($55.00)ViewN/AView Earnings Details
5/7/2014Q1 2014($0.15)($0.18)$1.65 million$1.48 millionViewN/AView Earnings Details
2/26/2014Q4 2013($40.00)ViewN/AView Earnings Details
11/11/2013Q114($0.11)($0.09)$1.60 million$2.30 millionViewN/AView Earnings Details
9/17/2013Q413($0.13)($0.10)$1.50 million$1.50 millionViewN/AView Earnings Details
5/8/2013Q313($0.27)$1.14 million$1.51 millionViewN/AView Earnings Details
2/4/2013Q4 2012$27.50ViewN/AView Earnings Details
11/2/2012Q3 2012($110.00)ViewN/AView Earnings Details
9/12/2012Q2 2012($50.00)ViewN/AView Earnings Details
5/8/2012Q1 2012($50.00)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

InspireMD (NYSEAMERICAN:NSPR) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for InspireMD (NYSEAMERICAN:NSPR)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

InspireMD (NYSEAMERICAN NSPR) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for InspireMD (NYSEAMERICAN:NSPR)

InspireMD (NYSEAMERICAN NSPR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/21/2016Paul StukaDirectorBuy127,119$0.59$75,000.21View SEC Filing  
5/29/2014Eric L OlsonVPBuy31,778$2.55$81,033.90View SEC Filing  
5/13/2014Sol J BarerDirectorBuy50,000$2.44$122,000.00View SEC Filing  
5/12/2014Alan MilinazzoCEOBuy7,100$2.36$16,756.00View SEC Filing  
11/26/2013Asher HolzerDirectorSell597,300$2.64$1,576,872.00View SEC Filing  
11/20/2013Asher HolzerDirectorSell1,600$2.69$4,304.00View SEC Filing  
5/31/2013Sol J BarerDirectorBuy20,000$2.26$45,200.00View SEC Filing  
5/30/2013Sol J BarerDirectorBuy20,000$2.07$41,400.00View SEC Filing  
5/29/2013Alan MilinazzoCEOBuy15,000$2.11$31,650.00View SEC Filing  
5/29/2013Sol J BarerDirectorBuy20,000$2.09$41,800.00View SEC Filing  
5/28/2013Sol J BarerDirectorBuy20,000$2.15$43,000.00View SEC Filing  
5/24/2013Sol J BarerDirectorBuy20,000$2.10$42,000.00View SEC Filing  
4/25/2013Sol J BarerDirectorBuy50,000$2.00$100,000.00View SEC Filing  
4/16/2013Alan MilinazzoCEOBuy100,000$2.00$200,000.00View SEC Filing  
4/16/2013Sol J BarerDirectorBuy750,000$2.00$1,500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

InspireMD (NYSEAMERICAN NSPR) News Headlines

Source:
DateHeadline
InspireMD Inc (NSPR) Sees Large Growth in Short InterestInspireMD Inc (NSPR) Sees Large Growth in Short Interest
www.americanbankingnews.com - January 10 at 6:06 PM
Today’s Research Reports on Trending Tickers: Akers Biosciences and InspireMD, Inc.Today’s Research Reports on Trending Tickers: Akers Biosciences and InspireMD, Inc.
finance.yahoo.com - January 10 at 10:20 AM
InspireMD (NSPR) Reports Approval of CGuard EPS in India and Agreement with Leading Indian Medical Device DistributorInspireMD (NSPR) Reports Approval of CGuard EPS in India and Agreement with Leading Indian Medical Device Distributor
www.streetinsider.com - January 5 at 4:23 PM
techstockinsider.com: 2 Medical Technology Stocks That Have Investors Attentiontechstockinsider.com: 2 Medical Technology Stocks That Have Investors' Attention
www.finanznachrichten.de - January 5 at 4:23 PM
2 Medical Technology Stocks That Have Investors Attention2 Medical Technology Stocks That Have Investors' Attention
finance.yahoo.com - January 3 at 4:42 PM
InspireMD Schedules Conference Call to Discuss Recent Developments, Preliminary Sales Results and Proposals for Upcoming Shareholder MeetingInspireMD Schedules Conference Call to Discuss Recent Developments, Preliminary Sales Results and Proposals for Upcoming Shareholder Meeting
finance.yahoo.com - January 3 at 4:42 PM
InspireMD Announces Regulatory Approval of CGuard EPS in India; Signs Agreement with Leading Indian Medical Device DistributorInspireMD Announces Regulatory Approval of CGuard EPS in India; Signs Agreement with Leading Indian Medical Device Distributor
finance.yahoo.com - January 3 at 9:32 AM
InspireMD Inc (NSPR) Sees Significant Increase in Short InterestInspireMD Inc (NSPR) Sees Significant Increase in Short Interest
www.americanbankingnews.com - December 27 at 6:38 PM
InspireMD’s CGuard™ Embolic Prevention System Once Again Featured in a Successful Live Clinical Case at Leading Industry ConferenceInspireMD’s CGuard™ Embolic Prevention System Once Again Featured in a Successful Live Clinical Case at Leading Industry Conference
finance.yahoo.com - December 18 at 4:38 PM
InspireMD Inc (NSPR) Short Interest UpdateInspireMD Inc (NSPR) Short Interest Update
www.americanbankingnews.com - December 12 at 1:50 AM
InspireMD’s CGuard EPS Demonstrates Improved Outcomes over Carotid Endarterectomy in 50 Patient Comparative Study; Preliminary Results Featured at the 7th Munich Vascular Conference 2017InspireMD’s CGuard EPS Demonstrates Improved Outcomes over Carotid Endarterectomy in 50 Patient Comparative Study; Preliminary Results Featured at the 7th Munich Vascular Conference 2017
finance.yahoo.com - December 7 at 4:56 PM
Five Innovative Biotech Stocks for the New YearFive Innovative Biotech Stocks for the New Year
www.prnewswire.com - December 7 at 10:37 AM
InspireMD Announces Preliminary 2 Year Follow-up Results from the PARADIGM Clinical Study Using CGuard™ EPSInspireMD Announces Preliminary 2 Year Follow-up Results from the PARADIGM Clinical Study Using CGuard™ EPS
finance.yahoo.com - December 5 at 4:37 PM
InspireMD Inc (NSPR) Sees Significant Growth in Short InterestInspireMD Inc (NSPR) Sees Significant Growth in Short Interest
www.americanbankingnews.com - November 27 at 8:24 PM

SEC Filings

InspireMD (NYSEAMERICAN:NSPR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

InspireMD (NYSEAMERICAN:NSPR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

InspireMD (NYSEAMERICAN NSPR) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.